摘要 |
Use for the vasculopathy treatment of compounds or salts thereof, having the following general formula: A-(B)b0-(C)c0-NO2 wherein A is the radical of the precursor drug selected between the salicylic or acetylsalicylic acid, B and C are bivalent linking groups as defined in the invention.
|